A Pivotal Phase 2b/3, Multicentre, Randomised, Open, Controlled Study on the Efficacy and Safety of Autologous Osteoblastic Cells (PREOB) Implantation in Non-Infected Hypotrophic Non-Union Fractures
Phase of Trial: Phase II/III
Latest Information Update: 22 Oct 2017
At a glance
- Drugs Autologous osteoblastic cell therapy Bone Therapeutics (Primary)
- Indications Non-union fracture
- Focus Therapeutic Use
- Sponsors Bone Therapeutics
- 16 Oct 2017 Planned End Date changed from 1 Jun 2017 to 1 Apr 2018.
- 16 Oct 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Apr 2018.
- 16 Oct 2017 Status changed from recruiting to discontinued.